Skip to main content

7 Result(s)

within G Guillerm Remove this filter

and

  1. No Access

    Article

    Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC

    Poly-chemotherapy plus rituximab followed by autologous stem cell transplantation (auto-SCT) is standard care for untreated young patients with mantle cell lymphoma (MCL). Despite this intensive treatment, tra...

    B Tessoulin, P Ceballos, P Chevallier, D Blaise… in Bone Marrow Transplantation (2016)

  2. No Access

    Article

    Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin’s lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)

    This report retrospectively analyzed the outcome of 91 patients aged 60 years or older with refractory/relapsed (R/R) classical Hodgkin's lymphoma (cHL) who underwent autologous stem cell transplantation (ASCT...

    A Stamatoullas, P Brice, M S Gueye, S Mareschal… in Bone Marrow Transplantation (2016)

  3. No Access

    Article

    Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

    Peripheral T-cell lymphoma carries a poor prognosis. To document a possible graft-versus-lymphoma effect in this setting, we evaluated the impact of immunomodulation in 63 patients with peripheral T-cell lymph...

    A-C Mamez, V Lévy, P Chevallier, D Blaise, S Vigouroux… in Bone Marrow Transplantation (2016)

  4. No Access

    Article

    Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

    Previous data suggested that allo-SCT might be an effective therapy in the setting of chemo-refractory/relapsed diseases because of the potent long-term immune-mediated tumor control. This retrospective study ...

    P Chevallier, M Labopin, N Milpied, K Bilger, G Socié… in Bone Marrow Transplantation (2014)

  5. No Access

    Article

    Experience (1 year) of G-CSF biosimilars in PBSCT for lymphoma and myeloma patients

    J-C Ianotto, A Tempescul, X Yan, P Delepine, R Le Calloch… in Bone Marrow Transplantation (2012)

  6. No Access

    Article

    ESHAP chemotherapy regimen associated to lenalidomide induces complete isotopic remission in Hodgkin’s lymphoma relapsing after autologous stem cell transplantation

    A. Tempescul, J. C. Ianotto, J. R. Eveillard, G. Guillerm… in Annals of Hematology (2011)

  7. No Access

    Article

    Allogeneic bone marrow transplantation in patients with follicular lymphoma: a single center study

    The role of allogeneic BMT for follicular lymphoma remains to be established. From 1995 to 2000, 16 patients with follicular lymphoma underwent allogeneic BMT at our center. At the time of transplantation, two...

    I Yakoub-Agha, A Fawaz, O Folliot, G Guillerm, B Quesnel… in Bone Marrow Transplantation (2002)